Compounds and methods for treating depression
    39.
    发明授权
    Compounds and methods for treating depression 失效
    用于治疗抑郁症的化合物和方法

    公开(公告)号:US4421767A

    公开(公告)日:1983-12-20

    申请号:US417751

    申请日:1982-09-13

    摘要: Compounds of the formula: ##STR1## wherein: X is fluorine, chlorine, or bromine;R is the group R.sub.2 as defined below;R.sub.1 is a group of the formula: ##STR2## or the group R.sub.2 as defined below; wherein R.sub.2 is: ##STR3## wherein R.sub.3 is hydrogen, (C.sub.1 -C.sub.4)alkyl, or (C.sub.1 -C.sub.4)alkoxy, andR.sub.4 is (C.sub.1 -C.sub.4)alkyl or (C.sub.1 -C.sub.4)alkoxy;or a (C.sub.1 -C.sub.8)alkyl ester thereof; or a non-toxic pharmaceutically acceptable salt thereof, inhibit MAO in vivo and can be administered either alone or in combination with an aromatic L-amino acid decarboxylase inhibitor for the treatment of depression.

    摘要翻译: 下式的化合物:其中:X是氟,氯或溴; R是如下定义的基团R2; R1是下式定义的一组:或R2; 其中R 2是氢,(C 1 -C 4)烷基或(C 1 -C 4)烷氧基,且R 4是(C 1 -C 4)烷基,(C 1 -C 4) C4)烷基或(C1-C4)烷氧基; 或其(C1-C8)烷基酯; 或其无毒的药学上可接受的盐在体内抑制MAO,并且可以单独或与芳族L-氨基酸脱羧酶抑制剂组合施用以治疗抑郁症。